CD274 and cancer: In a recent study by Cortellini et al., cancer patients administered steroids, PPIs, and systemic antibiotics had significantly worse clinical outcomes on PD-1/PD-L1 inhibitors, presumably due to their detrimental effect on the immune system [6].